Tirzepatide suppresses appetite so effectively that some people inadvertently fast for extended periods, driving blood sugar dangerously low
Is BPC-157 FDA-approved in either oral or injectable form
his fits for your business & your goals Given your direction (you run The Wellness Lounge in Anchorage, youre doing IV therapies, youre branching into peptides, youre interested in body-recomposition, fat vs fluid tracking, inflammation control, mobility recovery) here are some bespoke notes: AOD 9604 could slot nicely into a 12-week body-recomposition protocol (which you already are designing) as the fat-metabolism component, paired with your IV therapies, peptide stacks, training/movement protocols, inflammation support
In contrast, the MCT-KD provided 80% from fat (including 25% from MCT oil), 1015% from protein, and 510% from carbohydrates